News & Events

Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.

Symbiosis launches new website!

On the 13th June, Symbiosis launched its new website, to reflect its continued client focus and its growing international reputation as a world class cGMP manufacturer of sterile injectable pharmaceuticals for clinical trials.The new website offers users a more visually enhanced experience full of new images and better graphics such as a 3D animated “fly-through” of the Symbiosis manufacturing facility, generated from the… Read More

Symbiosis appoints new Business Development Manager

Symbiosis Pharmaceutical Services, a leading small-scale contract manufacturer of novel injectable pharmaceuticals for use in clinical trials, is pleased to announce the arrival of a new Business Development Manager, Joanne Anderson.With her employment we are strengthening our sales and marketing function. She will become a key point of communication for existing and new clients.She will be responsible for securing target sales through… Read More

Top 3 Reasons Why We’re Different!

By combining over 60 years of industry experience and by asking clients what was important to them before we built our facility, we identified and implemented the following:Flexibility – we can adapt our operational processes and systems to fit our clients’ project, and not the other way around. In practice that includes our approach to how we design and efficiently deliver our technical documentation and how we… Read More

Symbiosis is celebrating…

This month Symbiosis is celebrating its 2nd anniversary.As you can see from the photos below, we’ve come a long way!After listening to our clients we have developed a business that is focused on their needs.We have transformed a building site into a world class sterile manufacturing facility, been granted our GMP license and expanded our team to 20.Most importantly we have developed… Read More

Another successful regulatory milestone achieved

Leading on from the receipt of our Investigational Medicinal Products (IMP-MA) manufacturing licence from the UK Government regulator, the MHRA, in early 2012, Symbiosis hosted its first full MHRA cGMP inspection in December 2012.Not surprisingly, we are delighted to share with you that the inspection was successfully concluded to the satisfaction of the MHRA.This is another significant achievement for Symbiosis and is… Read More

Symbiosis opens contract injectables plant for early phase

“Our objective is to actively and aggressively drive down the amount of highly valuable drug development time”, Colin Mackay, Founder and CEORead the full story here :

Symbiosis launches multi-million pound sterile drug manufacturing capability in Scotland

Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish). Symbiosis has successfully completed clinical trial manufacturing projects with clients from across Europe and Asia, including Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) and Encap Drug Delivery. The UK Government regulator, the… Read More

Get In Touch